OSTN and Hypertension: This biphasic feature of “low basal level-pathological compensatory increase” suggests that Musclin may play a different role in different stages of hypertension (such as vascular homeostasis vs. end organ injury), or be regulated by secondary factors such as inflammation and oxidative stress.